The trajectory of Sildenafil presents a interesting case for observers in the pharmaceutical sector. While initially a phenomenal success, producing billions, the intellectual property end and the subsequent arrival of https://pharma885141.fare-blog.com/42169064/the-little-copyright-and-big-pharma-a-hazardous-investment